Clinical trial
The Effect of a Weight Management Program During Treatment With Olanzapine
NCT00169702 · Heinrich-Heine University, Duesseldorf, Other · Completed
Key facts
| NCT number | NCT00169702 |
|---|---|
| Title | The Effect of a Weight Management Program During Treatment With Olanzapine |
| Official title | The Effect of a Weight Management Program to Prevent Weight Gain and Metabolic Abnormalities During Treatment With the Atypical Neuroleptic Olanzapine: A Randomised Study |
| Lead sponsor | Heinrich-Heine University, Duesseldorf, Other |
| Collaborators | Eli Lilly and Company Industry Else Kröner-Fresenius-Centre for Nutritional Medicine Technical University of Munich |
| Status | Completed |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Behavioral |
| Interventions | weight management program |
| Enrollment | 100 |
| Start date | Jun 1, 2003 |
| Completion | Jul 1, 2007 |
| First posted | Sep 15, 2005 |
| Last update posted | Jan 30, 2008 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: